[1]
Angeline Suma Davis 2020. A review on Remdesivir (GS-5734) for the treatment of Covid-19. International Journal of Research in Pharmaceutical Sciences. 11, SPL1 (Dec. 2020), 1662-1667. DOI:https://doi.org/10.26452/ijrps.v11iSPL1.4134.